Who invested in Oncoinvent

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2017, from 1 source

Latest round: Round, $25MFeb 2017
Investors: 5

See who backed them

The rounds

Feb 2017
Round$25M
- Canica
- CGS Holding
- Geveran Trading
- Helene Sundt
- Must Invest
Reported by FinSMEs

Founders and team

From Oncoinvent's own website: 10 on the team.

Anders MånssonChief Executive Officer
Øystein SougChief Executive Officer
Anne-Kirsti AksnesChief Clinical Officer
Gro HjellumChief Operating Officer
Kari MyrenChief Medical Officer
Kristine LofthusChief Production Officer
Ramzi AmriChief Financial Officer
Sara WestrømChief Scientific Officer
Anne Cecilie AlvikHead of Quality Assurance
Kaja Tunhøvd JohansenHead of Quality Control

Everyone who backed them

CanicaVC firm1round

CGS Holdingno record of our own yet1round

Geveran Tradingno record of our own yet1round

Helene Sundtno record of our own yet1round

Must Investno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Oncoinvent as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.